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Pulmonary hypertension (PH) results in right ventricular
(RV) hypertrophy and dilation that could lead to the
development of arrhythmogenic substrates for cardiac
arrhythmias, which are important predictors and contributors
to morbidity and mortality in these patients.1 To date, the
mechanism of ventricular arrhythmia in patients with PH are
less well understood.
Here, we reported a case presenting sustained and non-
sustained ventricular arrhythmia owing to the increased
automaticity of the right Purkinje arborization in a patient
with severe chronic PH and the promising effectiveness of
radiofrequency catheter ablation in elimination of the ven-
tricular arrhythmia.
Case presentation
An 83-year-old woman had history of atrial ﬁbrillation (AF)
with controlled ventricular response and chronic PH. She
was clinically stable on medical therapy but developed 1
month of dyspnea, dizziness, and near syncope. The echo-
cardiography revealed severely dilated left and right atria,
severe PH (RV systolic pressure of 74.9 mm Hg) with
moderate tricuspid regurgitation, mild RV hypertrophy, and
mild RV systolic dysfunction. Her 24-hour Holter monitorKEYWORDS Ventricular tachycardia; Ventricular premature complex;
Pulmonary hypertension; Ablation; Purkinje potential; Automaticity
ABBREVIATIONS AF ¼ atrial fibrillation; ECG ¼ electrocardiogram;
MB ¼ moderator band; PH ¼ pulmonary hypertension; RV ¼ right
ventricular; VPC ¼ ventricular premature complex; VT ¼ ventricular
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This work was supported by National Central University (grant no.
CNJRF-99CGH-NCU-A3), the Center for Dynamical Biomarkers and
Translational Medicine, Ministry of Science and Technology (102-2314-
B-010-056-MY2, NSC 102-2911-I-008-001, NSC 101-2911-I-008-001,
NSC 100-2314-B-010-033-MY3, NSC 99-2628-B-075-007-MY3),
Research Foundation of Cardiovascular Medicine (RFCM 96-02-018, 97-
02-029, 98-01-020, 98-02-032, 99-01-022, 100-01-004, 100-02-011, 100-
02-022, 101-01-001), and Taipei Veterans General Hospital (V102C-128,
V103E7-003, VN103-04, V103C-042, V104B-018). Address reprint
requests and correspondence: Dr Yenn-Jiang Lin, Division of Cardiology,
Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2,
Shih-Pai Rd, Taipei, Taiwan. E-mail address: linyennjiang@gmail.com.
2214-0271 B 2016 Heart Rhythm Society. Published by Elsevier Inc. This is an o
(http://creativecommons.org/licenses/by-nc-nd/4.0/).demonstrated incessant wide QRS complex tachycardia with
a mean ventricular rate of 124 bpm. Figure 1 demonstrated
the 12-lead electrocardiogram (ECG) before and during wide
QRS complex tachycardia. Antiarrhythmic drugs with amio-
darone and verapamil were used after admission to coronary
care unit, with unsatisfactory effects. The recorded ECG
monitoring showed frequent nonsustained wide QRS com-
plex tachycardia. What is the mechanism of the wide QRS
complex tachycardia?
Electrophysiological study
After providing informed consent, the patient underwent an
electrophysiological study in fasting state without sedation.
A multielectrode catheter was placed in the RV apex in
standard fashion. The initial rhythm presented with AF with
both narrow and wide QRS complexes. The wide QRS
complex morphology was left bundle branch block, superior
axis, V5 transition with QRS duration of 142 msec. His
potential was recorded occurring after the wide QRS com-
plex during tachycardia, supporting the diagnosis of ven-
tricular tachycardia/ventricular premature complexes (VT/
VPC). Drug test with adenosine did not suppress the VT/
VPC. The 3D geometry was created by the CARTO 3.2
UDM system (Biosense-Webster, Baldwin Park, CA) using a
3.5-mm-tip open-irrigated catheter (Thermocool; Biosense-
Webster) and voltage mapping depicted no remarkable low
voltage zone or abnormal fractionated electrograms
(Figure 2A). Activation mapping of the VT/VPC demon-
strated the earliest activation site localized at the anterior mid
free wall of the right ventricle, and a Purkinje potential
preceded the onset of wide QRS tachycardia by 30 msec.
Pace mapping at the earliest activation site yielded 12/12
leads matched QRS morphology (Figure 2B). Radiofre-
quency energy was delivered in a temperature-controlled
mode at 30-35 watts targeting for an impedance drop of 10
ohms. The morphology of VT/VPC changed in leads I, II, III,
AVL, AVF, V3, and V4 after initial attempts of ablation.
Remapping of the VT/VPC demonstrated the earliest acti-
vation localized near the previous ablation site at a distance
of 11.2 mm. Similarly, a Purkinje potential preceding VT/
VPC by 32 msec was noted, while pace mapping also yieldedpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.10.003
KEY TEACHING POINTS
 Currently, human studies on the mechanisms of
ventricular arrhythmias in patients with pulmonary
hypertension are still lacking.
 The Purkinje system may play a role in the
arrhythmogenesis of ventricular tachycardia in
patients with pulmonary hypertension.
 The recording of discrete potentials from the
Purkinje system provides help in the effectiveness
in elimination of right Purkinje system–related
ventricular tachycardia by radiofrequency catheter
ablation.
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frequency ablation successfully terminated VT/VPC. After
ablation, VPCs and nonsustained VT were not inducible by
the infusion of isoprenaline and programmed stimulation.
The patient was uneventful during clinical follow-up 3
months later.Discussion
During wide QRS complex tachycardia, it is important to
differentiate between supraventricular and ventricular origin
of the arrhythmia in order to guide us in clinical manage-
ment. The irregular cycle length of wide QRS complex
tachycardia might easily be misinterpreted as aberrant
conduction during AF. Also, using the Brugada algorithm2Figure 1 The 12-lead electrocardiogram (ECG) at baseline and during tachycard
B: ECG during wide QRS complex tachycardia with left bundle branch block moin this case did not differentiate the wide QRS tachycardia as
supraventricular tachycardia with bundle branch block
aberrancy from VT. However, the recording of His potential
after the wide QRS complex during electrophysiologic study
and the earliest activation sites localized at anterior mid RV
free wall supported the diagnosis of VT/VPCs.
The activation map of the nonsustained VT/VPCs showed
the focal earliest activation from the right Purkinje system.
Purkinje potentials were recorded 30 msec and 32 msec
earlier than the VT/VPCs from the 2 successful ablation sites
(shown in the ablation catheter bipolar electrogram in
Figure 2B and C). The Purkinje potentials at the successful
ablation sites preceding the ventricular activation were
also noted during AF with narrow QRS complexes. The
recording of discrete potentials from the Purkinje system
provides help in localization and facilitating ablation of these
arrhythmias.3
In this case, it is also possible that VT/VPCs originated
from the moderator band (MB), which usually extends from
the septum to the RV free wall and encompasses the RV
Purkinje ﬁbers.4 VPC arising from the MB may variably
arise from the septal insertion site, from the body, and from
the RV free wall insertion site. The Purkinje system is a
complex network of ﬁbers that spreads through the sub-
endocardium of the right and left ventricles and VT/VPCs
may arise from these ﬁbers surrounding the MB.
In contrast to idiopathic left fascicular VTs, which mostly
could be suppressed by verapamil,5,6 the VT/VPCs demon-
strated poor response to either verapamil or amiodarone,
implying different electrophysiologic characteristics in
this case. Moreover, a focal activation pattern with radialia. A: The baseline ECG showed atrial ﬁbrillation and narrow QRS complex.
rphology, a superior axis, V5 transition, and QRS duration of 142 msec.
Figure 2 Voltage and substrate mapping. A: Voltage mapping depicted no remarkable low voltage zone (deﬁned by voltageo1.5 mV). B: The activation
map of the ventricular tachycardia (VT) / ventricular premature complex (VPC) demonstrated the earliest activation site localized at the anterior mid free wall of
the right ventricle, and a Purkinje potential (*) preceded the onset of wide QRS tachycardia by 30 msec. Pace mapping at the earliest activation site yielded 12/12
leads matched QRS morphology. C: Remapping after initial ablation showed another VT/VPC originating from the foci at a distance of 11.2 mm from the
previous ablation site with a Purkinje potential (*) preceding VT/VPC by 32 msec. Pace mapping at the foci also yielded 12/12 leads matched QRS morphology
comparing with the documented VT/VPC. Radiofrequency ablation successfully terminated the VT/VPC.
65Te et al Irregular Wide QRS Complex Tachycardia in Pulmonary Hypertensionspreading of VT/VPCs activation map and irregular VT
cycle lengths proved that the mechanism of ventricular
arrhythmia was less likely to be re-entrant, while triggered
activity was excluded by the fact that VT/VPCs were also
unresponsive to adenosine. To the best of our knowledge,
sustained VTs owing to automaticity of the right Purkinje
system and manifesting as electrical storm in a patient with
chronic PH have not been previously reported.
Purkinje ﬁbers have been implicated in both the initiation
and the maintenance of ventricular tachyarrhythmias in
animal models.7,8 Haïssaguerre et al9 also demonstrated the
role of the Purkinje system in triggering of idiopathic
ventricular ﬁbrillation. Several previous studies10–12 demon-
strated that the spontaneous re-entrant ventricular arrhythmiaoriginating from conduction system might become frequent
in patients who have developed conduction abnormalities in
the His-Purkinje system. Additionally, early afterdepolariza-
tion–mediated triggered activity in failing RV cardiomyo-
cytes as the mechanism for initiation of nonsustained VT has
been demonstrated in rats with monocrotaline-induced PH
and RV failure.13
Previous study demonstrated that supraventricular arrhyth-
mias such as AF and atrial ﬂutter contribute to the worsened
outcomes in patients with PH.1 In addition, prospective and
retrospective studies by Bandorski et al14,15 showed increased
incidence of nonsustained VT in patients with chronic PH
undergoing electrophysiological study or a 72-h Holter ECG.
However, these studies were limited by moderate sample size
Heart Rhythm Case Reports, Vol 2, No 1, January 201666and the lack of underlying pathophysiological mechanism
of ventricular arrhythmias. To date, studies on recognition
of the origin of ventricular arrhythmias in patients with PH
are still lacking and are warranted for further prospective
investigation.
In conclusion, we reported a case with nonsustained and
irregular wide QRS complex tachycardia originating from
right Purkinje arborization owing to the increased automaticity
in the patient with chronic PH. Mapping the earliest Purkinje
potential could provide help and promising effectiveness on
elimination of VT/VPCs by radiofrequency catheter ablation.References
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